Get the HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test for only $200 in USA. This genetic test helps prevent severe skin reactions to epilepsy medications. Available in New York
Get the HLA Hypersensitivity to Allopurinol B5801 Test for only $200 USD. This genetic test identifies patients at risk for severe allopurinol reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis. Available nationwide in major cities like New York HLA Hypersensitivity to Allopurinol B5801 Test Original price was: $300.Current price is: $200.
Get comprehensive CYP2C9 Gene Coumarin/Warfarin Resistance DNA testing for $500 USD. Advanced NGS technology detects genetic variants affecting blood thinner medication response. Available in New York CYP2C9 Gene Coumarin/Warfarin Resistance Due to CYP2C9 Variants Genetic Test Original price was: $700.Current price is: $500.
Sale!

HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test

Original price was: $300.Current price is: $200.

-33%

The HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test is a crucial genetic screening that identifies individuals at risk for severe adverse reactions to common anti-epileptic medications. This advanced molecular test detects the presence of the HLA-B*1502 allele, which is strongly associated with dangerous skin conditions like Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis when patients take carbamazepine or phenytoin. The test provides essential information for neurologists and dermatologists to make safer medication choices, particularly for patients of Asian descent who have higher prevalence of this genetic marker. With results available in 10-12 days and no special preparation required, this test offers peace of mind and personalized treatment planning. The discounted price is $200 USD, making advanced genetic testing accessible for better patient safety.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test

Understanding Genetic Drug Hypersensitivity Testing

The HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test represents a breakthrough in personalized medicine, offering critical genetic insights that can prevent life-threatening medication reactions. This advanced pharmacogenetic screening specifically identifies individuals carrying the HLA-B*1502 allele, a genetic marker strongly associated with severe cutaneous adverse reactions to commonly prescribed anti-epileptic drugs.

What This Test Measures and Detects

This sophisticated genetic analysis utilizes PCR and sequencing methodologies to precisely identify the presence of the HLA-B*1502 allele in your DNA. The test specifically detects:

  • Presence of HLA-B*1502 genetic variant
  • Genetic predisposition to carbamazepine hypersensitivity
  • Risk factors for phenytoin-induced severe skin reactions
  • Individual susceptibility to Stevens-Johnson Syndrome
  • Genetic markers for Toxic Epidermal Necrolysis risk

Who Should Consider This Genetic Screening

This test is particularly important for individuals who:

  • Are being considered for anti-epileptic medication therapy
  • Have a family history of medication hypersensitivity reactions
  • Belong to Asian ethnic backgrounds (higher prevalence)
  • Experience unexplained skin rashes with previous medications
  • Require long-term neurological treatment management
  • Show symptoms of potential drug sensitivity including skin blistering, fever, or mucosal involvement

Clinical Benefits of Genetic Testing

Undergoing the HLA Hypersensitivity test provides numerous advantages:

  • Prevention of Severe Reactions: Identifies risk before medication administration
  • Personalized Treatment Plans: Enables safer alternative medication selection
  • Reduced Hospitalization Risk: Prevents costly and dangerous adverse events
  • Improved Patient Safety: Provides crucial information for neurologists and dermatologists
  • Lifelong Genetic Insight: One-time test with permanent clinical value

Understanding Your Test Results

Your genetic test results will fall into one of two categories:

  • Positive for HLA-B*1502: Indicates increased risk for severe hypersensitivity reactions to carbamazepine and phenytoin. Your healthcare provider will recommend alternative anti-epileptic medications.
  • Negative for HLA-B*1502: Suggests standard risk for medication reactions. However, always follow your physician’s guidance regarding medication management.

It’s essential to discuss your results with a qualified healthcare professional who can interpret them in the context of your complete medical history and treatment needs.

Test Information and Pricing

Test Feature Details
Test Name HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test
Regular Price $300 USD
Discount Price $200 USD
Turnaround Time 10-12 days
Sample Type 4 mL whole blood in EDTA tube OR 6 mL whole blood in ACD tube OR Buccal swab
Preparation No special preparation required

Nationwide Testing Availability

We have diagnostic branches conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our nationwide network ensures accessible genetic testing for patients throughout the country.

Take Control of Your Medication Safety

Don’t leave your medication safety to chance. The HLA Hypersensitivity to Carbamazepine Phenytoin B1502 Test provides essential genetic information that can guide your healthcare providers toward safer treatment decisions. With our discounted price of $200 USD and comprehensive testing network, advanced genetic screening has never been more accessible.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment or get more information about this life-saving genetic screening.

SKU: 1176 Category:

Related products